MICHELLE HAMILTON: Open Payments
NPI 1154986677 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,755 in 84 payments from 16 companies in 2025. Trend: 2023 $1,017 · 2024 $1,183 · 2025 $1,755
Food & beverage: $1,755
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 20 | $378 |
| Insmed, Inc. | 16 | $311 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $162 |
| JAZZ PHARMACEUTICALS INC. | 6 | $149 |
| Verona Pharma, Inc. | 8 | $141 |
| GENZYME CORPORATION | 4 | $135 |
| Actelion Pharmaceuticals US, Inc. | 4 | $111 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
| Amgen Inc. | 2 | $47 |
Products named: NUCALA, Arikayce, DUPIXENT, XYWAV, Ohtuvayre, TEZSPIRE, OFEV, JASCAYD.
Industry payments across FL — which companies pay providers there.
